|
CE1226 Clinical Trials
1 actively recruiting trial
Also known as: Human alpha1-proteinase inhibitor, Respreeza, Zemaira
Pipeline
Phase 4: 1
Top Sponsors
- CSL Behring1
Indications
- Alpha1-Proteinase Inhibitor Deficiency1
- Alpha1-Antitrypsin Deficiency1
- Liver Disease1
- Emphysema1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.